1. Expression of Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Neurotrophin-3 mRNAs in Human Cortical Xenografts. (1995) Authors: Humpel, Christian; Strömberg, Ingrid; Olson, Lars Journal: Journal of neural transplantation & plasticity Issue: Volume 5:Number 4(1994) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fibrin Glue Used as an Adhesive Agent in CNS Tissues. (1995) Authors: Cheng, Henrich; Almström, Susanne; Olson, Lars Journal: Journal of neural transplantation & plasticity Issue: Volume 5:Number 4(1994) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glial Cell Line-Derived Neurotrophic Factor Partially Ameliorates Motor Symptoms without Slowing Neurodegeneration in Mice with Respiratory Chain-Deficient Dopamine Neurons. Issue 9 (September 2013) Authors: Sterky, Fredrik H.; Pernold, Karin; Harvey, Brandon K.; Lindqvist, Eva; Hoffer, Barry J.; Olson, Lars Journal: Cell transplantation Issue: Volume 22:Issue 9(2013) Page Start: 1529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease. (2nd June 2020) Authors: Glotfelty, Elliot J.; Olson, Lars; Karlsson, Tobias E.; Li, Yazhou; Greig, Nigel H. Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 6(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease. (2nd June 2020) Authors: Glotfelty, Elliot J.; Olson, Lars; Karlsson, Tobias E.; Li, Yazhou; Greig, Nigel H. Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 6(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Minor Immunoreactivity in GDNF-, BDNF-, or NT-3-Treated Substantia Nigra Allografts. (1997) Authors: Shinoda, Masaki; Hoffer, Barry J.; Olson, Lars Journal: Journal of neural transplantation & plasticity Issue: Volume 6:Number 2(1997) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. USING PROTEOMICS TO ELUCIDATE HOW VOLUNTARY EXERCISE COMBATS AGING PHENOTYPES IN MTDNA MUTATOR MICE. (11th November 2018) Authors: Ross, J M; Coppotelli, Giuseppe; Branca, R; Lehtiö, J; Sinclair, D; Olson, Lars Journal: Innovation in aging Issue: Volume 2(2018)Supplement 1 Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice. Issue 6 (6th September 2019) Authors: Ross, Jaime M.; Coppotelli, Giuseppe; Branca, Rui M.; Kim, Kyung M.; Lehtiö, Janne; Sinclair, David A.; Olson, Lars Journal: Aging cell Issue: Volume 18:Issue 6(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗